This contract is designed to evaluate the activity and toxicity of Suramin in patients with AIDS and AIDS-related illnesses, including non-Hodgkin's lymphoma. Patients will receive Suramin for a period of one year and a number of parameters will be monitored including virology, pharmacokinetics, immune status and clinical response.
Monto, A S; Sullivan, K M (1993) Acute respiratory illness in the community. Frequency of illness and the agents involved. Epidemiol Infect 110:145-60 |
Monto, A S; Koopman, J S; Bryan, E R (1986) The Tecumseh Study of Illness. XIV. Occurrence of respiratory viruses, 1976-1981. Am J Epidemiol 124:359-67 |